Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATEZOLIZUMAB Cause Peritonitis bacterial? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Peritonitis bacterial have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.0% of all adverse event reports for ATEZOLIZUMAB.

8
Reports of Peritonitis bacterial with ATEZOLIZUMAB
0.0%
of all ATEZOLIZUMAB reports
4
Deaths
3
Hospitalizations

How Dangerous Is Peritonitis bacterial From ATEZOLIZUMAB?

Of the 8 reports, 4 (50.0%) resulted in death, 3 (37.5%) required hospitalization.

Is Peritonitis bacterial Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does ATEZOLIZUMAB Cause?

Death (3,591) Off label use (2,340) Disease progression (1,828) Pyrexia (1,599) Diarrhoea (1,490) Fatigue (1,253) Anaemia (1,195) Pneumonia (1,036) Nausea (953) Dyspnoea (938)

What Other Drugs Cause Peritonitis bacterial?

CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (4,672) CALCIUM\ICODEXTRIN\MAGNESIUM\SODIUM\SODIUM (804) DIANEAL LOW (461) RIBAVIRIN (134) EXTRANEAL (110) TACROLIMUS (92) CALCIUM\DEXTROSE\HYDROCHLORIC ACID\MAGNESIUM\SODIUM BICARBONATE\SODIUM\SODIUM HYDROXIDE\SODIUM (86) SOFOSBUVIR (85) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM (53) ICODEXTRIN (51)

Which ATEZOLIZUMAB Alternatives Have Lower Peritonitis bacterial Risk?

ATEZOLIZUMAB vs ATLANTIC SALMON OIL ATEZOLIZUMAB vs ATOGEPANT ATEZOLIZUMAB vs ATOMOXETINE ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE ATEZOLIZUMAB vs ATORVASTATIN

Related Pages

ATEZOLIZUMAB Full Profile All Peritonitis bacterial Reports All Drugs Causing Peritonitis bacterial ATEZOLIZUMAB Demographics